Ligand validation:8T5V

E4Z: Baloxavir acid

E4Z is a Ligand Of Interest in 8T5V designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8T5V_E4Z_A_303	63%	5%	0.116	0.91	2.61	2.7	16	13	0	0	100%	1
8T5W_E4Z_A_303	76%	4%	0.097	0.932	2.43	3.19	15	15	0	1	100%	1
6FS6_E4Z_C_903	59%	10%	0.136	0.918	1.75	2.57	6	7	0	0	100%	1
6FS7_E4Z_E_903	57%	13%	0.121	0.895	1.76	2.18	7	7	0	0	100%	1
6FS8_E4Z_A_201	92%	18%	0.078	0.968	1.54	1.98	7	9	0	0	100%	1
7KBC_E4Z_A_201	80%	2%	0.116	0.965	3	3.69	11	15	1	0	100%	1
7KAF_E4Z_A_201	79%	2%	0.12	0.967	3.07	3.49	11	17	0	0	100%	1
7K0W_E4Z_A_201	79%	40%	0.123	0.97	0.98	1.36	4	6	0	0	100%	1
6FS9_E4Z_A_203	69%	11%	0.138	0.953	2	2.18	9	11	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.